Houlihan Lokey Advises Torreya

Houlihan Lokey is pleased to announce that Torreya Partners LLC (Torreya), a leading independent M&A and private capital advisory firm serving the global life sciences industry, has been acquired by Stifel Financial Corp. (Stifel). The transaction closed on March 1, 2023.

Founded in 2007, Torreya has deep specialization within life sciences, including biotechnology and pharmaceuticals. In addition to its core M&A business, Torreya also offers advisory expertise across divestitures and joint ventures, royalty monetization, licensing agreements, and private capital raising. With a team of more than 40 professionals located in New York, London, and Mumbai, Torreya maintains international presence in a sector that demands cross-border capabilities and significant global reach.

Stifel (NYSE:SF) is a financial services holding company headquartered in St. Louis that conducts banking, securities, and financial services business. The combination builds upon Stifel’s healthcare investment banking team, with Torreya viewing Stifel as the right partner to help accelerate growth across industry, product, and geographic coverage.